Global Medical Supplies & Consumables Market Outlook, 2031

The global medical supplies and consumables industry covers single-use and short-life products used in hospitals, clinics, laboratories, long-term care facilities and homes to diagnose, treat and care for patients. Products include gloves, gowns, masks and other personal protective equipment; syringes, needles and infusion sets; catheters, tubes and drainage products; wound care dressings; surgical drapes, sutures and staplers; sterilisation and disinfection products; diagnostic test kits and laboratory consumables; incontinence products; respiratory consumables; dialysis consumables; diabetes supplies such as test strips and pen needles; and intravenous fluids. The market is characterised by very high volumes, relatively low prices per unit and complex global supply chains. Major manufacturers and distributors include Medline, the largest US provider of medical-surgical products, which completed the biggest US initial public offering of 2025; Cardinal Health; Owens & Minor; McKesson; Henry Schein; Becton Dickinson; Baxter; B. Braun; Fresenius Kabi; 3M's former health care business Solventum; Johnson & Johnson MedTech; Medtronic; Smith & Nephew; Mölnlycke; ConvaTec; Coloplast; Teleflex; Cardinal's and Medline's private-label brands; and glove makers such as Top Glove, Hartalega and Kossan in Malaysia. China is a major producer of many basic supplies, including gloves, masks, gowns and syringes.

The pandemic exposed the fragility of medical supply chains. In early 2020, hospitals worldwide ran short of masks, gowns, gloves and swabs as demand soared and exports from China were disrupted, forcing health workers to reuse protective equipment and governments to intervene in procurement. Prices for gloves and masks spiked before collapsing as capacity expanded and demand fell, leaving glove makers with excess capacity. Since then, governments have sought to reduce dependence on single countries. The United States raised Section 301 tariffs on Chinese syringes and needles to 100% in 2024 and on medical gloves to 50% in 2025 and 100% in 2026, and in 2025 the Commerce Department opened a Section 232 investigation into imports of medical devices, protective equipment and consumables. Supply shocks have continued: in October 2024 Hurricane Helene flooded Baxter's North Cove plant in North Carolina, which produced about 60% of US intravenous fluids, causing a national shortage that lasted months. Environmental rules have also affected supply, including the US Environmental Protection Agency's 2024 rule tightening emissions limits for ethylene oxide sterilisers, which sterilise about half of US medical devices. Medline's December 2025 initial public offering, which raised USD 6.26 billion, underlined investor interest in medical supply chains.

Market Dynamics Market Drivers • Rising Healthcare Utilisation and Ageing PopulationsAgeing populations, higher rates of chronic disease and growing numbers of surgical procedures increase consumption of medical supplies in hospitals, outpatient centres, long-term care and homes. Older patients use more wound care, incontinence, catheter and diabetes supplies, and the shift of care to home and outpatient settings creates demand for home medical supplies. Expanding healthcare access in emerging markets adds to volumes.
• Infection Prevention and Safety StandardsHospital-acquired infections, antimicrobial resistance and lessons from the pandemic have increased emphasis on infection prevention, supporting demand for gloves, gowns, drapes, disinfectants, sterilisation products and single-use devices. Regulations and guidelines require safety-engineered needles, closed-system transfer devices for hazardous drugs and single-use products for certain procedures. Stockpiling of protective equipment by governments and hospitals also supports demand.

Market Challenges • Supply Chain Vulnerability and Trade PolicyProduction of many medical supplies is concentrated in a few countries and facilities, making the market vulnerable to disasters, pandemics and trade disputes. The IV fluid shortage after Hurricane Helene in 2024 and pandemic shortages of protective equipment showed the risks. US tariffs on Chinese medical supplies and potential Section 232 measures raise costs and force companies to reorganise sourcing, while other countries consider similar policies.
• Price Pressure and Low MarginsMany medical consumables are commodities purchased through group purchasing organisations and tenders that emphasise low prices, limiting margins for manufacturers and distributors. Hospitals face financial pressure and seek to cut supply costs. Glove and mask makers experienced a sharp fall in prices after the pandemic. Rising costs for raw materials, energy, labour, freight and regulatory compliance squeeze margins further.

Market Trends • Reshoring and Supply Chain DiversificationGovernments and companies are building production capacity closer to end markets and diversifying suppliers to reduce reliance on China. US incentives, tariffs and procurement preferences encourage domestic production of gloves, masks, gowns, syringes and IV fluids, while manufacturers expand in Mexico, Central America, India, Southeast Asia and Eastern Europe. Hospitals and distributors are increasing inventory buffers and using data to monitor supply risks.
• Sustainability and Reduction of Single-Use WasteHealthcare produces large amounts of plastic waste and greenhouse gas emissions, and hospitals and governments are seeking more sustainable supplies. Reprocessing of certain single-use devices, reusable gowns and sterilisation containers, recyclable packaging and lower-emission sterilisation methods are gaining attention. The UK's NHS has set targets to reach net zero emissions, and suppliers are introducing products with lower environmental impact.



Segment Analysis Infusion and injection products, wound care, and personal protective equipment are among the largest medical supply categories, while diagnostic consumables and home care supplies are growing strongly. Infusion and injection products, including syringes, needles, IV catheters, infusion sets, IV fluids and pumps' disposable sets, are used in almost every hospital patient and in vaccination programmes, and BD, B. Braun, Baxter, ICU Medical, Terumo and Fresenius Kabi are major suppliers. Wound care products, including traditional dressings, advanced foam, hydrocolloid and antimicrobial dressings, negative pressure wound therapy consumables and skin substitutes, treat surgical wounds, pressure ulcers, diabetic foot ulcers and burns. Personal protective equipment, including gloves, gowns, masks, respirators and face shields, is consumed in huge volumes. Surgical supplies include drapes, sutures, staplers, surgical instruments for single use and procedure packs. Catheters and tubes, including urinary catheters, feeding tubes and respiratory tubes, are widely used. Diagnostic consumables include test kits, specimen collection products, blood collection tubes and laboratory plastics. Sterilisation and disinfection products include disinfectants, sterilisation wraps and indicators. Incontinence and ostomy products serve patients at home and in care facilities, with Coloplast, ConvaTec and Hollister leading ostomy care. Respiratory consumables include oxygen masks, nebulisers and CPAP supplies. Diabetes supplies, dialysis consumables and radiology contrast accessories form further segments.

Disposable single-use products account for the largest share of medical supplies, while reusable and reprocessed products form a smaller segment gaining interest for sustainability reasons. Disposable single-use products dominate the market because they reduce the risk of cross-infection, remove the need for cleaning and sterilisation, and provide consistent performance. Gloves, syringes, needles, catheters, dressings, drapes, masks and many surgical instruments are designed for single use. Regulations and infection control practices have increased the use of disposables over several decades. Reusable products, including surgical gowns and drapes made from durable fabrics, sterilisation containers, some instruments and devices, are cleaned and sterilised between uses, and they can reduce waste and cost over time. Reprocessed single-use devices, such as certain catheters and surgical tools, are cleaned, tested and resterilised by regulated third-party reprocessors, including Stryker Sustainability Solutions and Innovative Health, and are used by many US hospitals to cut costs and waste. Biodegradable and recyclable materials are being developed for packaging and some products. The balance between disposable and reusable products is influenced by infection control, cost, sterilisation capacity, environmental regulation and hospital sustainability goals.

Hospitals account for the largest share of medical supply consumption, while ambulatory care, long-term care and home care settings are the fastest-growing end users. Hospitals consume the largest volume and value of medical supplies, used in surgery, intensive care, emergency departments, wards and laboratories, and they purchase through group purchasing organisations such as Vizient, Premier and HealthTrust in the United States and national procurement bodies in Europe and elsewhere. Ambulatory surgery centres and outpatient clinics use surgical supplies, procedure packs and diagnostic consumables, and their share grows as procedures move out of hospitals. Physician offices and dental practices use examination gloves, syringes, dressings and diagnostic supplies. Long-term care facilities, including nursing homes and assisted living, use incontinence products, wound care, gloves and personal care supplies in large quantities. Home care settings are a fast-growing end user, as patients manage diabetes, ostomies, wounds, respiratory conditions and dialysis at home, with supplies delivered by home medical equipment providers and mail-order distributors. Clinical and diagnostic laboratories use specimen collection and laboratory consumables. Pharmacies sell consumer medical supplies such as bandages, thermometers and test kits. Military, emergency services and government stockpiles form further segments.

Distributors supply the majority of medical consumables to healthcare providers, while direct sales, e-commerce and group purchasing arrangements shape how products reach customers. Medical-surgical distributors, including Medline, Cardinal Health, Owens & Minor, McKesson Medical-Surgical and Henry Schein in the United States, and companies such as Mediq, Bunzl Healthcare and others in Europe, supply most hospitals, clinics and care homes with consumables, managing warehousing, logistics and inventory. Several distributors also sell their own private-label products, which offer lower prices than branded products. Direct sales by manufacturers are common for specialised products, such as advanced wound care, surgical devices, dialysis consumables and ostomy supplies, where clinical support is important. Group purchasing organisations negotiate contracts on behalf of hospitals, influencing which products and suppliers are used. Tenders and national procurement agencies buy supplies for public health systems, including NHS Supply Chain in England. E-commerce and online channels, including Amazon Business and distributors' online ordering platforms, have grown for physician offices, dental practices and home care customers. Retail pharmacies and consumer channels sell over-the-counter supplies. Home medical equipment providers and mail-order suppliers deliver products directly to patients, often reimbursed by insurers.

Regional Analysis North America leads the medical supplies and consumables market because of high healthcare spending, heavy use of single-use products and large distribution companies, while Asia-Pacific is both the fastest-growing consumption region and the largest manufacturing base. North America, led by the United States, accounts for the largest share of medical supply spending, reflecting high rates of hospital use, surgery and chronic disease, extensive use of disposable products and a sophisticated distribution system dominated by Medline, Cardinal Health, Owens & Minor and McKesson. Medline's December 2025 IPO, the largest US listing of the year, highlighted the scale of the sector. US policy has focused on supply chain resilience, including Section 301 tariffs on Chinese syringes, needles and gloves, the 2025 Section 232 investigation into medical supplies and equipment, and incentives for domestic manufacturing, while the IV fluid shortage after Hurricane Helene in 2024 exposed vulnerabilities. Canada relies heavily on imports. Europe is the second largest region, with high use of medical supplies in hospital-centred health systems, strong manufacturers such as B. Braun, Fresenius, Mölnlycke, Coloplast and Smith & Nephew, and increasing focus on sustainability and supply security under EU policies. Asia-Pacific is the fastest-growing region by consumption, as healthcare spending rises in China, India, Southeast Asia and elsewhere, and it is the world's largest manufacturing base: China produces large shares of global PPE, syringes and other supplies, Malaysia dominates rubber glove production, and India, Vietnam and Thailand are expanding manufacturing. Japan has a large mature market. Latin America, the Middle East and Africa have growing demand, with Mexico and Central America becoming nearshoring hubs for US-bound medical supplies.

Key Developments December 2025: Medline raised USD 6.26 billion in its Nasdaq initial public offering, valuing the medical-surgical supplier at about USD 39 billion at pricing.
September 2025: The US Commerce Department began an investigation into imports of medical devices, personal protective equipment and consumables, which could lead to new tariffs.
October 2024: Flooding shut Baxter's North Cove plant in North Carolina, which produced about 60% of US IV fluids, triggering a nationwide shortage and conservation measures in hospitals.
September 2024: Section 301 tariffs on Chinese syringes and needles rose to 100%, with tariffs on medical gloves scheduled to increase to 50% in 2025 and 100% in 2026.
April 2024: 3M completed the separation of its health care business as Solventum, a major supplier of wound care, infection prevention and medical consumables.
March 2024: The US Environmental Protection Agency finalised stricter emissions limits for commercial sterilisers using ethylene oxide, which sterilise about half of US medical devices.

Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031

Aspects covered in this report
• Global Medical Supplies & Consumables Market with its value and forecast along with its segments
• Various drivers and challenges
• Ongoing trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Infusion and Injection Products
• Wound Care Products
• Personal Protective Equipment
• Surgical Supplies
• Catheters and Tubes
• Diagnostic Consumables
• Incontinence and Ostomy Products

By Usability
• Disposable Products
• Reusable Products
• Reprocessed Products

By End User
• Hospitals
• Ambulatory Care Centres
• Long-Term Care Facilities
• Home Care Settings
• Clinics and Laboratories

By Distribution Channel
• Medical-Surgical Distributors
• Direct Sales
• Tenders and Group Purchasing
• E-Commerce and Retail